Fintel reports that on June 3, 2025, Wells Fargo upgraded their outlook for Cencora (NYSE:COR) from Equal-Weight to ...

Amazon, CVS Health and Walgreens — are licking their financial wounds after multibillion-dollar investments in primary care ...

Cherny covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Hims & Hers Health, and Quest Diagnostics. ;'> Currently, the analyst consensus on Cencora is a Moderate Buy ...

Walgreens Boots Alliance has been acquired by Sycamore Partners for nearly $10 billion, aiming to revitalize the company after enduring financial challenges. The acquisition will transition ...

Walgreens Boots Alliance says it has agreed ... and it's been reducing its stake in the drug distributor Cencora this year to get cash in part to pay down debt. Ultimately, the company has to ...

Walgreens said Thursday that Sycamore will ... and it’s been reducing its stake in the drug distributor Cencora this year to get cash in part to pay down debt. Ultimately, the company has ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive $300 million from an early settlement of some prepaid shares of Cencora ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

Walgreens Boots settles prepaid share contracts early, generating $300M in proceeds. WBA reduces Cencora stake from 10% to 6% to support debt reduction. Rebound or breakdown? See how Matt Maley is ...

Walgreens Boots Alliance’s ownership of Cencora’s common stock has decreased from approximately 10 percent to approximately six percent.

(Reuters) - U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for proceeds of about $300 million. The company said that it now owns a 6 ...